Inside Moderna’s Personalized Cancer Vaccine
a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck’s individualized treatment for melanoma, after more than a decade of work on personalized cancer vaccines. Stéphane explains how the treatment…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like The a16z Show →
Andreessen Horowitz's Vijay Pande: "AI doctors"
The breakthrough science of mRNA medicine | Melissa J. Moore
Moderna's Cancer Vaccine Breakthrough & Why Uber Could Win the Robotaxi War
What an mRNA melanoma vaccine may mean for cancer treatment
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.